|
KR20090033878A
|
|
Pharmaceutical composition for alleviation and treatment of ischemic conditions and method for delivering the same
|
|
KR20080098729A
|
|
Method of transferring protein in cytoplasm
|
|
KR20080084937A
|
|
Methods for fusion polypeptide delivery into a cell
|
|
KR20070005345A
|
|
2,5-dihydro-4-alkyl-2,5-dioxofuran derivative and the use thereof
|
|
KR100553174B1
|
|
The fusion peptide-ptd conjugates for improving skin-wrinkle and cosmetics containing the same
|
|
KR20050054119A
|
|
Immunosuppressant comprising xanthorrhizol
|
|
KR20050041163A
|
|
Antitumor agents comprising tautomycetin
|
|
KR20040041991A
|
|
Dna/rna transduction technology and its clinical and basic applications
|
|
KR20030062789A
|
|
Biomolecule transduction peptide sim2-btm and biotechnological products including it
|
|
KR20030062788A
|
|
Biomolecule transduction peptide mph1-btm and biotechnological products including it
|
|
KR20020084347A
|
|
Microbial composition as an additive to livestock feeds
|
